Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Konstantin Sparrer and Carina Conzelmann.
Konstantin Sparrer
Connection Strength
0.974
Carina Conzelmann
  1. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities. Cell Rep. 2021 05 18; 35(7):109126.
    View in: PubMed
    Score: 0.236
  2. Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19. Clin Med (Lond). 2020 11; 20(6):e218-e221.
    View in: PubMed
    Score: 0.225
  3. An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection. Antiviral Res. 2020 09; 181:104882.
    View in: PubMed
    Score: 0.224
  4. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat Commun. 2021 07 28; 12(1):4584.
    View in: PubMed
    Score: 0.060
  5. Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nat Commun. 2021 03 19; 12(1):1726.
    View in: PubMed
    Score: 0.058
  6. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021 02; 3(2):149-165.
    View in: PubMed
    Score: 0.058
  7. Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal Organoids. Cell Mol Gastroenterol Hepatol. 2021; 11(4):935-948.
    View in: PubMed
    Score: 0.057
  8. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans. mBio. 2020 10 16; 11(5).
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.